Our products target urological diseases with large unmet medical needs : lower urinary tract dysfunctions and uro-oncology. These diseases are not well served by currently available medications and represent some of the largest pharmaceutical markets in the world.

In addition, they have complex etiologies and significant evidence of efficacy for innovative drugs can only be brought about by clinical proof-of-concept.